REGN vs. NVO
Compare and contrast key facts about Regeneron Pharmaceuticals, Inc. (REGN) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: REGN or NVO.
Correlation
The correlation between REGN and NVO is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
REGN vs. NVO - Performance Comparison
Key characteristics
REGN:
-1.48
NVO:
-1.27
REGN:
-2.13
NVO:
-1.91
REGN:
0.74
NVO:
0.75
REGN:
-0.76
NVO:
-0.88
REGN:
-1.46
NVO:
-1.87
REGN:
27.12%
NVO:
26.63%
REGN:
26.80%
NVO:
39.32%
REGN:
-91.81%
NVO:
-71.29%
REGN:
-52.22%
NVO:
-56.57%
Fundamentals
REGN:
$62.69B
NVO:
$283.79B
REGN:
$38.36
NVO:
$3.31
REGN:
14.95
NVO:
18.90
REGN:
0.91
NVO:
0.96
REGN:
$11.06B
NVO:
$225.05B
REGN:
$9.40B
NVO:
$190.45B
REGN:
$3.94B
NVO:
$113.24B
Returns By Period
In the year-to-date period, REGN achieves a -19.39% return, which is significantly higher than NVO's -26.11% return. Over the past 10 years, REGN has underperformed NVO with an annualized return of 2.66%, while NVO has yielded a comparatively higher 10.75% annualized return.
REGN
-19.39%
-16.55%
-43.31%
-38.72%
3.09%
2.66%
NVO
-26.11%
-30.05%
-44.79%
-48.54%
17.85%
10.75%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
REGN vs. NVO — Risk-Adjusted Performance Rank
REGN
NVO
REGN vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Regeneron Pharmaceuticals, Inc. (REGN) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
REGN vs. NVO - Dividend Comparison
REGN's dividend yield for the trailing twelve months is around 0.15%, less than NVO's 2.58% yield.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
REGN Regeneron Pharmaceuticals, Inc. | 0.15% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 2.58% | 1.68% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% |
Drawdowns
REGN vs. NVO - Drawdown Comparison
The maximum REGN drawdown since its inception was -91.81%, which is greater than NVO's maximum drawdown of -71.29%. Use the drawdown chart below to compare losses from any high point for REGN and NVO. For additional features, visit the drawdowns tool.
Volatility
REGN vs. NVO - Volatility Comparison
The current volatility for Regeneron Pharmaceuticals, Inc. (REGN) is 11.68%, while Novo Nordisk A/S (NVO) has a volatility of 13.88%. This indicates that REGN experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
REGN vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Regeneron Pharmaceuticals, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities